MSJAX
Price
$18.52
Change
-$0.40 (-2.11%)
Updated
Jul 11 closing price
Net Assets
30.16M
RLLGX
Price
$75.59
Change
-$0.81 (-1.06%)
Updated
Jul 11 closing price
Net Assets
78.5B
Interact to see
Advertisement

MSJAX vs RLLGX

Header iconMSJAX vs RLLGX Comparison
Open Charts MSJAX vs RLLGXBanner chart's image
Morgan Stanley Global Endurance A
Price$18.52
Change-$0.40 (-2.11%)
VolumeN/A
Net Assets30.16M
American Funds SMALLCAP World R6
Price$75.59
Change-$0.81 (-1.06%)
VolumeN/A
Net Assets78.5B
MSJAX vs RLLGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MSJAX vs. RLLGX commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSJAX is a Hold and RLLGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLLGX has more cash in the bank: 78.5B vs. MSJAX (30.2M). RLLGX pays higher dividends than MSJAX: RLLGX (0.92) vs MSJAX (0.00). MSJAX was incepted earlier than RLLGX: MSJAX (7 years) vs RLLGX (16 years). MSJAX (2.04) is less costly to investors than RLLGX (0.65). MSJAX is a more actively managed with annual turnover of: 157.00 vs. RLLGX (32.00). RLLGX has a lower initial minimum investment than MSJAX: RLLGX (250) vs MSJAX (1000). MSJAX annual gain was more profitable for investors over the last year : 22.49 vs. RLLGX (7.47). RLLGX return over 5 years is better than : 20.91 vs. MSJAX (8.14).
MSJAXRLLGXMSJAX / RLLGX
Total Expense Ratio1.350.65208%
Annual Report Gross Expense Ratio2.040.65314%
Fund Existence7 years16 years-
Gain YTD12.2428.017153%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets30.2M78.5B0%
Annual Yield % from dividends0.000.92-
Returns for 1 year22.497.47301%
Returns for 3 years63.1735.89176%
Returns for 5 years8.1420.9139%
Returns for 10 yearsN/A49.65-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRTX0.960.09
+10.06%
XORTX Therapeutics
ABOS1.400.10
+7.69%
Acumen Pharmaceuticals
VPG28.51-0.35
-1.21%
Vishay Precision Group
SNN30.28-0.79
-2.54%
Smith & Nephew plc
PD14.87-0.95
-6.01%
PagerDuty